← Back to Clinical Trials
Recruiting NCT07439224

NCT07439224 Qigong and Multicomponent Exercise in Panic Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07439224
Status Recruiting
Phase
Sponsor Dokuz Eylul University
Condition Panic Disorder
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-12-01
Primary Completion 2028-01-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Exercise Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-12-01 with a primary completion date of 2028-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Panic disorder is a psychiatric disease characterized by recurrent panic attacks that occur in expected or unexpected situations and create feelings of intense fear, restlessness and discomfort. Panic disorder often has a chronic course, its frequency and severity can be irregular, various physical, mental, and behavioral symptoms can develop, and the quality of life of individuals can decrease significantly. Evidence-based psychotherapy and pharmacotherapy are effective in reducing the symptoms of panic disorder and managing the disorder. However, both of these treatment methods have certain limitations, and approximately one-third of patients do not respond to therapy or the response is not sufficiently effective. Delaying treatment of the disease results in a poor prognosis and more established symptoms. Exercise can be viewed as a low-cost, supportive treatment for relieving symptoms with comparable efficacy to medication and other psychological interventions. Although exercise is recommended for patients with anxiety-panic disorder, there remains uncertainty about whether its effects are sustainable, the type and intensity of exercise required for effective treatment, and thus the effects of qigong and multicomponent exercise on multiple health outcomes in panic disorder. The aim of this study is to examine the effects of Qigong exercise training and multicomponent exercise training on anxiety-panic, balance, mobility, walking, functional strength, physical activity, sleep quality, fatigue, chronic musculoskeletal pain, quality of life and cognition.

Eligibility Criteria

Inclusion Criteria: * Being between the ages of 18-65 * Being diagnosed with "panic disorder" by a psychiatrist * Not having another psychiatric illness * Wanting to participate in the research voluntarily and signing the informed consent * Not having a history of communication or neuromusculoskeletal disease that would not allow the application of evaluation and treatment methods Exclusion Criteria: * Having a vision and/or hearing problem that would prevent participation in the study * History of neurological, cardiopulmonary and musculoskeletal system disease that would negatively affect participation in evaluation and treatment

Frequently Asked Questions

Who can join the NCT07439224 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Panic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07439224 currently recruiting?

Yes, NCT07439224 is actively recruiting participants. Visit ClinicalTrials.gov or contact Dokuz Eylul University to inquire about joining.

Where is the NCT07439224 trial being conducted?

This trial is being conducted at Izmir, Turkey (Türkiye).

Who is sponsoring the NCT07439224 clinical trial?

NCT07439224 is sponsored by Dokuz Eylul University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology